info@crogroup.com
The CRO Group
  • Who We Are
    • Our Expertise
    • Meet The Team
    • Careers
  • What We Offer
    • Services
      • Auditing
      • Training
      • Clearances & Approvals
      • Certifications
      • Cybersecurity Services
      • Design Assurance
    • Markets
      • mHealth
      • OTC Products
        • Aesthetic Premarket & Manufacturing Readiness
        • SaMD Wearable Development & Clinicals
      • Safety Critical Systems
  • Resources
    • Seminars & Warning Letters
  • News
  • Contact Us
Select Page

MEDDEV 2.7.1 Rev 4 Turns Up Clinical Compliance Heat This Summer

by Brian | Jul 4, 2016 | Guidance Documents

The latest revision of MEDDEV 2.7.1 published last month is more or less a total re-write, and may up-end manufacturer’s clinical plans as well as studies underway to support CE Marking but not yet submitted in tech file or design dossier.  In line with the...
Next Entries »

Categories

  • Guidance Documents
  • New/Updated Regulation
  • SaMD Related

Recent Posts

  • FDA Issues Informed Consent Final Guideline
  • We’re Back!
  • EU Clarifies Software Regulated under MDR/IVDR
  • Australia TGA Issues Electronic IFU Guidance
  • RED replaces R&TTE 13 June 2017 – Is Your Legacy Medical Device Ready?

Archives

Recent Posts

  • FDA Issues Informed Consent Final Guideline
  • We’re Back!
  • EU Clarifies Software Regulated under MDR/IVDR
  • Australia TGA Issues Electronic IFU Guidance

Follow Us on Twitter

Tweets by @@crogroup
  • Privacy Statement
  • Terms and Conditions
  • Facebook
  • X
©The CRO Group 2025
We use cookies to ensure that we give you the best experience on our website.
If you continue to use this site we will assume that you are happy with it.
Ok